Loading...
Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease with a highly variable phenotypic expression, ranging from asymptomatic to drug refractory heart failure (HF) presentation. Pharmacological therapy is the first line of treatment, but options are currently limited to nons...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268685/ https://ncbi.nlm.nih.gov/pubmed/34281272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22137218 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|